SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Bellis Pharma
Bellis Pharma Spółka z Ograniczoną Odpowiedzialnością w Upadłości
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Bellis Pharma Spółka z Ograniczoną Odpowiedzialnością w Upadłości
Bellis Pharma Spółka z Ograniczoną Odpowiedzialnością w Upadłości (KRS 0000616059, NIP 7922294605) is a Polish company, headquartered in Kraków, Małopolskie voivodeship. BELLIS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W UPADŁOŚCI operates in: Agents involved in the sale of a variety of goods (PKD 46.19.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since May 5, 2016.
Bankruptcy proceedings
Bankruptcy proceedings are underway against the company.
Main activity
46.19.ZAgents involved in the sale of a variety of goods
Other activities
Founded
May 5, 2016
10 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
KRAKÓW
MAŁOPOLSKIE
Primary PKD
46.19.Z
Agents involved in the sale of a variety of goods
Share capital
40.0 K PLN
100 shares total
Shareholders
4
shareholders
Board
2 people
Filed years
N/A
Registry entries
24
latest: June 24, 2025
Risk signals
No KPI data - financial statements and valuation are unavailable for this company.
Rate business credibility - Bellis Pharma.
No ratings

Explainer
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.

Explainer
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
20 historical registry entries for Bellis Pharma
Change in Section 4 (arrears and enforcement)
KR.XI NS-REJ.KRS/4377/21/646
Company name change, Change in Section 6 (liquidation, bankruptcy or dissolution)
KR.XI NS-REJ.KRS/2833/22/124
Change in Section 6 (liquidation, bankruptcy or dissolution)
KR.XI NS-REJ.KRS/29588/22/942
Filing document
Filing documents submitted (2 documents)
Filing document
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
BELLIS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W UPADŁOŚCI's board has 2 members.
Latest reporting year
2023
Available years
8
Filing entries
0
Trademarks filed or registered by Bellis Pharma in the Polish Patent Office (UPRP) - filing dates, status, Nice classes and graphical marks.
3 most recent trademarks

czyteo
Filing date: 2019-04-05
expiredCZYTEO
Filing date: 2019-03-25
expiredBELLISPHARMA
Filing date: 2019-02-04
activeCompeting companies or those operating in the same market segment as Bellis Pharma (in Kraków, industry: Wholesale trade).
KRAKÓW· Wholesale trade
Revenue 2024: 228.7 M PLN
KRAKÓW· Wholesale trade
Revenue 2024: 80.3 M PLN
KRAKÓW· Wholesale trade
Revenue 2024: 79.9 M PLN
KRAKÓW· Wholesale trade
Revenue 2023: 73.5 M PLN
KRAKÓW· Wholesale trade
Revenue 2024: 63.1 M PLN
KRAKÓW· Wholesale trade
Revenue 2024: 25.8 M PLN